Showing 1 - 10 of 55
condition for designing effective policies is to identify who drives antibiotic treatment decisions, physicians or patient …
Persistent link: https://www.econbiz.de/10013218285
This paper investigates the effect of physicians on infant mortality, stillbirths and the incidence of common childhood … endogeneity of health care supply is addressed by using the expulsion of Jewish physicians from health insurance schemes by the … control function approach. Our results indicate that the marginal returns to physicians are highly nonlinear and decreasing …
Persistent link: https://www.econbiz.de/10012908713
expulsion of Jewish physicians from statutory health insurance as exogenous variation in regional physician supply. Increases in … the supply of physicians reduce infant mortality and mortality from common childhood diseases. Using a semiparametric …
Persistent link: https://www.econbiz.de/10013292046
We examine the strategic interaction in the market for physician services when the total budget for reimbursement is fixed. We show that this prospective payment system involves ƒ{ compared to a fee-for-service remuneration system ƒ{ a severe coordination problem, which potentially leads to...
Persistent link: https://www.econbiz.de/10010315220
there is substantial variation in the quality of physicians, as measured by patients’ post-assignment mortality, in the …
Persistent link: https://www.econbiz.de/10014082234
We analyze prescription behavior of physicians in the public and private sector. We study two major diseases for which … private sector physicians are more likely to prescribe the expensive medication. The result holds after controlling for … our cases, we further find that the same physicians prescribe different medication when working in different sectors …
Persistent link: https://www.econbiz.de/10014263219
Although measures of sensitivity to inequality are important in judging the welfare effects of health-care programmes, it is far from straightforward how to elicit them and apply them in health-care decision making. This paper provides an overview of the literature on the measurement of...
Persistent link: https://www.econbiz.de/10012892077
surveys empirical evidence on medical R&D incentives, R&D costs of pharmaceuticals, and the cost-effectiveness of health …
Persistent link: https://www.econbiz.de/10013322775
Economists use micro-based and macro-based approaches to assess the macroeconomic return to population health. The macro-based approach tends to yield estimates that are either negative and close to zero or positive and an order of magnitude larger than the range of estimates derived from the...
Persistent link: https://www.econbiz.de/10014081589
Pharmaceutical firms spend increasing amounts in mergers and acquisitions (M&As), which raises the question of whether sufficient investment is left after mergers to further develop firms' internal drug development capability. We evaluate the effects of M&As on firms' post-merger R&D investments...
Persistent link: https://www.econbiz.de/10012833741